Geoffrey Hird Email

Chief Technology Officer . Glycomine

Current Roles

Employees:
24
Revenue:
$1.9M
About
Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist. The company's approach is to use replacement therapies – substrates, enzymes, or proteins – and to target those molecules to clinically relevant cellular compartments. Glycomine’s lead drug candidate, GLM101, is a novel substrate replacement therapy in development to treat phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG), a rare disease representing a critical unmet medical need.
Glycomine Address
733 Industrial Road
San Carlos, CA
Glycomine Email

Past Companies

Glycomine Inc.Chief Technology Officer
Glycomine Inc.VP of Pharmaceutical Development and CMC
Silver Cedar Pharmaceutical Consulting LLCPresident and CEO

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.